H, M., RK, S., AJ, M., Y, B., JM, M., SE, C., . . . PD, T. (2026). Comparative evaluation of the activity of novel β-lactam antibiotics against difficult-to-treat Pseudomonas aeruginosa clinical isolates. JAC-antimicrobial resistance, 8(4), dlag138. https://doi.org/10.1093/jacamr/dlag138
Chicago Style (17th ed.) CitationH, Mystakelis, Shields RK, Mathers AJ, Bergman Y, Munita JM, Cosgrove SE, Simner PJ, and Tamma PD. "Comparative Evaluation of the Activity of Novel β-lactam Antibiotics Against Difficult-to-treat Pseudomonas Aeruginosa Clinical Isolates." JAC-antimicrobial Resistance 8, no. 4 (2026): dlag138. https://doi.org/10.1093/jacamr/dlag138.
MLA (9th ed.) CitationH, Mystakelis, et al. "Comparative Evaluation of the Activity of Novel β-lactam Antibiotics Against Difficult-to-treat Pseudomonas Aeruginosa Clinical Isolates." JAC-antimicrobial Resistance, vol. 8, no. 4, 2026, p. dlag138, https://doi.org/10.1093/jacamr/dlag138.